Xenoport, Inc.XNPT was a big mover last session, as its shares rose over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday's rally reverses the recent downtrend for the company, as the stock is now down almost 32% in the past one-month time frame.
Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Xenoport currently has a Zacks Rank #2 (Buy).
Another favorably ranked biomedical stock is Anika Therapeutics Inc. ANIK with a Zacks Rank #1 (Strong Buy).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.